B.1.1.7 variant

Concept

COVID-19 variant prevalent in the US, with a single amino acid substitution increasing binding affinity to ACE2, but still effectively neutralized by current vaccines.

Mentioned in 1 video

Videos Mentioning B.1.1.7 variant

#159-Peter Hotez MD, PhD.: The anti-vaccine movement, causes of autism, & COVID-19 vaccine update

#159-Peter Hotez MD, PhD.: The anti-vaccine movement, causes of autism, & COVID-19 vaccine update

Peter Attia MD

COVID-19 variant prevalent in the US, with a single amino acid substitution increasing binding affinity to ACE2, but still effectively neutralized by current vaccines.